BKYI — BIO-key International Balance Sheet
0.000.00%
- $5.01m
- $3.31m
- $6.93m
- 52
- 67
- 31
- 49
Annual balance sheet for BIO-key International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17.5 | 7.75 | 2.64 | 0.511 | 0.438 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.903 | 1.1 | 1.57 | 1.3 | 0.792 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 18.9 | 14 | 8.98 | 2.62 | 1.89 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.569 | 0.323 | 0.305 | 0.257 | 0.214 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 22.5 | 17.8 | 11.3 | 4.52 | 8.62 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.88 | 2 | 5.46 | 3.21 | 4.55 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.19 | 2.15 | 6.04 | 3.45 | 4.84 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 20.3 | 15.6 | 5.3 | 1.06 | 3.77 |
| Total Liabilities & Shareholders' Equity | 22.5 | 17.8 | 11.3 | 4.52 | 8.62 |
| Total Common Shares Outstanding |